EnableCV

EnableCV is a medical device company focused on advancing innovation in cardiac surgery. The company specializes in developing and commercializing minimally invasive surgical approaches and devices that enable a broad spectrum of cardiovascular procedures. Its portfolio includes advanced cannulae and occlusion devices designed to improve surgical outcomes and patient recovery. Originally developed within Edwards Lifesciences, EnableCV now operates as a specialized subsidiary (or independent entity under Edwards' ownership) focused on next-generation cardiac surgery solutions. The company leverages a deep heritage in structural heart technology to provide surgeons with tools for intra-aortic occlusion, retrograde cardioplegia delivery, and venous drainage during cardiopulmonary bypass.